OUHSC Research News – Monday, April 11, 2022

 

Notices and Reminders

Reminder: Research Integrity Training Requirement

All individuals at OUHSC who conduct or oversee research, who are eligible to conduct or oversee research - including managing research accounts (administrative and/or financial aspects of research accounts), must complete Research Integrity Training. Learn more at: https://research.ouhsc.edu/Research-Integrity or https://research.ouhsc.edu/Research-Integrity/Research-Integrity-Training-FAQs

Key Points:

• PI’s are responsible for ensuring all members of their research team have completed Research Integrity Training
• Business Managers should assign Research Integrity Training via ePAF to everyone in their unit whose duties fit the requirements to ensure the department’s compliance is recorded in PeopleSoft
• Anyone with an OUHSC email address can register with CITI Program, affiliate with the University of Oklahoma Health Sciences Center, and then add the required course: “Responsible Conduct of Research”; step-by-step instructions are attached
• Contact the Research Integrity Office for assistance or questions: ResearchIntegrity@ouhsc.edu or 405-271-7755

Reminder: ECAV Guidance. An "Application to Establish a Chartfield Attribute Value" form (ECAV) is used to establish projects with no external sponsor or those without a fully executed contract. This form is completed by the requesting department/Principal Investigator. If you are submitting an ECAV for a multi-project award, you only need to submit a single ECAV form. When you submit the ECAV form for the next year of the prime, please provide an Excel spreadsheet that includes which projects you want setup with ECAVs, as well as a budget breakdown for each. 

For the Streamlined Noncompeting Award Process (SNAP) awards from NIH, if there are additional years left on the award and the continuing year Notice of Award (NoA) hasn’t been received yet, you do not need to submit an ECAV. You only need to notify your accountant in the Grants & Contracts Accounting Office (GCA) via email and they will move the project to “K” status. A “K” status means “Continuation Pending”, so that you will be able to continue with the project as normal until GCA receives the NOA and moves it back into “Open” status.

ORA Reminder: Each senior/key personnel must electronically sign their respective NIH Other Support form. The version with the original electronic signature will need to be retained by the department, to be made available to NIH and/or ORA upon request. ORA will only keep the final flattened versions on file as part of the submission package and cannot serve as the central repository for the original signed copies of the Other Support.

ORA reminder: All research, training, professional, provider, public service, and clinical trial contracts, or any terms and conditions involved in the award document MUST be routed through ORA for legal, fiscal, and administrative review by an authorized agent of the Board of Regents of the University of Oklahoma in ORA. Individual faculty members are NOT authorized representatives of the University and may not negotiate or sign contracts or any award terms or conditions on behalf of the University.

 

OUHSC Funding Opportunities

Request for Proposals for COBRE Pilot Projects: Expanding Excellence in Developmental Biology in Oklahoma

Description: We are inviting the submission of pilot project proposals for funding through the Pilot Project Core of our Developmental Biology COBRE. Proposals should address novel, exciting research questions that are related to Developmental Biology and have outstanding potential to attract future NIH/NSF funding. Primary preference will be to junior investigators without prior NIH R01 or equivalent Federal support. Secondary preference will be for investigators at any level who are initiating new projects in Developmental Biology that require the generation of preliminary data for the subsequent submission of an investigator-initiated large-scale grant. Individuals with current COBRE or INBRE support are not eligible.

Application Submission Deadline: April 25, 2022

Link to Full Announcement: Please refer to the attached flyer.

Office of Technology Commercialization presents the following opportunities for researchers to engage with industry (click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).  

• One.Five, a biomaterials discovery company is seeking scientists and research groups with experience in paper modifications and coatings at lab and pilot scale. Out of scope: corrugated solutions, petroleum based solutions and oxo-degradable coatings. Submission entails a 1-pg non-confidential summary of technology (deadline 4/18)

College of Medicine Alumni Association (COMAA) Research Program

Description: Proposals are being accepted from full time faculty of the College of Medicine for grants to be awarded from the College of Medicine Alumni Association with proceeds generated from the Evening of Excellence dinner fund.  COMAA awards are intended to be an important resource for funding basic and clinical research projects of new and early stage investigators in the College of Medicine. The guidelines are included with this notice.

NOTE: All applications MUST be routed through the Office of Research Administration (ORA) and include the NIH face page (https://grants.nih.gov/grants/funding/phs398/fp1.pdf) signed by the appropriate ORA institutional official.

Application Submission Deadline: April 15, 2022

Link to Full Announcement: Please refer to the attached flyer.

 

 NIH Notices 

• Notice to Include Additional Application Due Dates for NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00)
  (NOT-DE-22-007)
• Notice of Early Termination of NOT-HG-22-006, Notice of Participation of Additional NIH Institutes and Centers in PAR-20-153: Science Education Partnership Awards (SEPA) (R25-Clinical Trial Not Allowed)
  (NOT-HG-22-016)
• Notice of Participation of Additional NIH Institutes and Centers in PAR-20-153: Science Education Partnership Awards (SEPA) (R25-Clinical Trial Not Allowed)
  (NOT-HG-22-017)
• Notice of Extension of NOT-HL-20-761 "Notice of Special Interest (NOSI): Pulmonary Complications of Hematopoietic Stem Cell Transplantation in Childhood"
  (NOT-HL-22-020)
• Modifications to the NIMH Special Council Review Procedures
  (NOT-MH-22-190)
• Request for Information (RFI): Identification of a Set of Determinants for Whole Person Health
  (NOT-AT-22-019)
• Request for Information (RFI): Seeking Input for the National Cancer Institute (NCI) on Advancing Research in Immuno-oncology, Immunoprevention, and/or Immunotherapy.
  (NOT-CA-22-072)
• Notice of Correction to RFA-CA-22-013, "PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24 Clinical Trial Not Allowed)"
  (NOT-CA-22-073)
• Notice of Expiration of NOT-HL-19-677 "Notice of Special Interest SEARCH: Stimulating ExplorAtory Research on HIV/AIDS Contribution to Heart, Lung, Blood and Sleep Comorbidities (R01 - Clinical Trial Not Allowed)"
  (NOT-HL-22-021)
• Notice of Participation of National Institute on Minority Health and Health Disparities (NIMHD) in PAR-22-137 & PAR-22-138, "Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study"
  (NOT-MD-22-014)
• Notice of Early Expiration of NOT-MH-22-085 Notice of Special Interest (NOSI): Administrative Supplements for NIMH Grants to Inform the Assessment of Suicide Thoughts and Behaviors among Children and Preteens
  (NOT-MH-22-196)
• Notice of Intent to Publish a Funding Opportunity Announcement for Research to Understand and Address the Survivorship Needs of Individuals Living with Advanced Cancer (R01 Clinical Trial Optional)
  (NOT-CA-22-077)
• Notice of Intent to Publish a Funding Opportunity Announcement for Precision Approaches in Radiation Synthetic combinations (PAIRS, R01 Clinical Trial Optional)
  (NOT-CA-22-078)
• Notice of Intent to Publish a Funding Opportunity Announcement for Precision Approaches in Radiation Synthetic combinations (PAIRS, R21 Clinical Trial Optional)
  (NOT-CA-22-079)
• Notice of Intent to Publish a Funding Opportunity Announcement for Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional)
  (NOT-MH-22-210)
• Notice of Intent to Publish a Funding Opportunity Announcement for Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed)
  (NOT-MH-22-211)
• Notice of Special Interest (NOSI): Administrative Supplements for Examining Patterns of Tobacco and Cannabis Use
  (NOT-CA-22-070)
• Notice of Special Interest (NOSI): Administrative Supplements for Research on Womens Health in the IDeA States
  (NOT-GM-22-005)
• Notice of Special Interest (NOSI): Administrative Supplements for NIMH Grants to Inform the Assessment of Suicide Thoughts and Behaviors among Children and Preteens
  (NOT-MH-22-195)

NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted).  The letters of intent will be reviewed and a single application will be chosen for submission from the University.

 

NIH Funding Opportunities

• National Institute of General Medical Sciences (NIGMS) Bridges to the Baccalaureate Research Training Program (T34)
  (PAR-22-125)
  Application Receipt Date(s): September 25, 2024
• Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional)
  (PAR-22-147)
  Application Receipt Date(s): Multiple dates, see announcement.
• Laboratories to Optimize Digital Health (R01 Clinical Trial Required)
  (PAR-22-154)
  Application Receipt Date(s): May 07, 2025
• Alcohol Health Services Research (R01 Clinical Trial Optional)
  (PAR-22-156)
  Application Receipt Date(s): May 07, 2023
• Alcohol Health Services Research (R34 Clinical Trial Optional)
  (PAR-22-157)
  Application Receipt Date(s): May 07, 2023
• Alcohol Treatment and Recovery Research (R01 Clinical Trial Required)
  (PAR-22-158)
  Application Receipt Date(s): May 07, 2023
• Alcohol Treatment and Recovery Research (R34 Clinical Trial Required)
  (PAR-22-159)
  Application Receipt Date(s): May 07, 2023
• Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)
  (PAR-22-161)
  Application Receipt Date(s): February 28, 2025
• Development and Optimization of Next-Generation Immunological Assays to Support Influenza Clinical Studies and Trials (UH2/UH3 Clinical Trial Not Allowed)
  (RFA-AI-22-020)
  Application Receipt Date(s): July 01, 2022
• Partnerships for the Development of Novel Therapeutics to Combat Select Antibiotic Resistant Bacteria and Fungi (R01 Clinical Trial Not Allowed)
  (RFA-AI-22-028)
  Application Receipt Date(s): July 29, 2022
• Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional)
  (RFA-CA-22-016)
  Application Receipt Date(s): September 27, 2022
• Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)
  (RFA-CA-22-020)
  Application Receipt Date(s): June 17, 2022
• SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
  (RFA-CA-22-025)
  Application Receipt Date(s): August 6, 2021
• Increasing Immediate Engagement and Retention in HIV Treatment with Substance Users (R01- Clinical Trials Required)
  (RFA-DA-23-002)
  Application Receipt Date(s): August 11, 2022
• NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
  (RFA-DC-23-001)
  Application Receipt Date(s): August 04, 2023
• A Community Research Resource: Characterization of the Resident Ocular Microbiome. (U24 Clinical Trial Not Allowed)
  (RFA-EY-22-001)
  Application Receipt Date(s): July 06, 2022
• Reducing Racial and Ethnic Healthcare Disparities in Chronic Conditions by Dissemination and Implementation of Patient Centered Outcomes Research (PCOR) Evidence (R18)
  (RFA-HS-22-001)
  Application Receipt Date(s): June 17, 2022
• Diagnostic Centers of Excellence: Partnerships to Improve Diagnostic Safety and Quality (R18)
  (RFA-HS-22-008)
  Application Receipt Date(s): June 09, 2022
• Limited Competition: Research Centers in Minority Institutions (RCMI) Clinical Research Network for Health Equity (UG3/UH3 - Clinical Trial Optional)
  (RFA-MD-22-006)
  Application Receipt Date(s): May 31, 2022
• INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed)
  (RFA-OD-22-007)
  Application Receipt Date(s): July 01, 2024
• Small Research Grants for Analysis, Curation, and/or Sharing of Down syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed)
  (RFA-OD-22-008)
  Application Receipt Date(s): Multiple dates, see announcement.
• Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed)
  (RFA-OD-22-009)
  Application Receipt Date(s): July 01, 2024
• Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required)
  (RFA-OD-22-010)
  Application Receipt Date(s): July 01, 2024
• Emergency Award: Rapid Acceleration of Diagnostics Tribal Data Repository (RADx TDR) (U24 Clinical Trial Not Allowed)
  (RFA-OD-22-011)
  Application Receipt Date(s): May 31, 2022
• NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
  (RFA-RM-22-019)
  Application Receipt Date(s): August 19, 2022

 

Other Funding Opportunities

Health Resources and Services Administration (HRSA) Public Health Scholarship Program (PHSP)

Description: The purpose of the PHSP is to strengthen the public health workforce by providing support to organizations to develop scholarship programs that incentivize individuals to pursue training and careers in public health. Through the PHSP, scholarship recipients will gain the requisite knowledge and skills necessary to prevent, prepare for, and respond to recovery activities related to COVID–19, as well as other public health emergencies.

Application deadline: June 1, 2022

Link to Full Announcement: https://www.hrsa.gov/grants/find-funding/hrsa-22-122

APsaA Fund for Psychoanalytic Research: Research Grant, Pilot Grant, Consultation Grant, Career Support Grant

Description: The Fund conceives of psychoanalytic research along the broadest lines, including: scholarly and empirical investigative contributions that can advance knowledge of psychoanalytic theory, practice, and links between psychoanalysis and neighboring disciplines such as developmental psychology or neuroscience. 

Applications Due: May 1, 2022

Link to Full Announcement: https://apsa.org/research-fund

The Cystic Fibrosis Foundation (CFF) Clinical Trials in Organ Transplant (CTOT)

Description: The CF Foundation is seeking applications for lung transplant research projects that aim to use available CTOT specimens and/or data to improve knowledge of Chronic Lung Allograft Dysfunction (CLAD) pathogenesis and explore new approaches to detection, prevention, monitoring or treatment of CLAD. For questions, please contact lungtransplant@cff.org

LOI deadline: April 20, 2022

Full Application deadline: August 23, 2022. 

Link to Full Announcement: https://www.cff.org/sites/default/files/2022-03/Clinical-Trials-in-Organ-Transplantation-Ancillary-Studies-Policies-and-Guidelines.pdf

The Vilcek Foundation 2023 Vilcek Prizes for Creative Promise in Biomedical Science

Description: The Vilcek Foundation will award three Creative Promise Prizes of $50,000 each to young, immigrant biomedical scientists who demonstrate outstanding early achievement. Applicants should have been born outside of the United States and be 38 years of age or younger, but limited exceptions to the age requirement will be granted to those who have taken time off for caregiving, medical, military, or parental leave. Three winners will each receive a $50,000 unrestricted cash prize and be honored at an awards ceremony in New York City in April 2023. 

Deadline: June 10, 2022

Link to Full Announcement: https://vilcek.org/prizes/vilcek-prizes-for-creative-promise/creative-promise-prizes-biomedical-science/

Pandemic Antiviral Discovery (PAD) Henipavirus – Request for proposals 2022

Description: This RFP will support projects that seek to elucidate the molecular determinants of henipavirus replication, pathogenesis and transmission for the purpose of developing therapeutic discovery programs targeting virus and/or host-specific targets important for virus replication. Projects can be of both novel and exploratory nature and of later-stage validation/developmental nature.

Deadline: May 5, 2022

Link to Full Announcement: https://padinitiative.com/henipavirus-request-for-proposals-2022/

DoD FY22 Autism Research Program (ARP)

• Clinical Trial Award (CTA)            

• Idea Development Award (IDA)
• Career Development Award (CDA)

Pre-Application (Preproposal): May 23, 2022

Invitation to Submit an Application: June 2022

Application: August 18, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/arp

DoD FY22 Ovarian Cancer Research Program (OCRP)

• Pilot Award (PA)             
• Proteogenomics Research Award (PGRA)            
• Ovarian Cancer Academy Award - Early-Career Investigator (OCA)          
• Investigator-Initiated Research Award (IIRA)     

Pre-Application (Preproposal): May 2, 2022

Application: August 5, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/ocrp

DoD FY22 Orthotics and Prosthetics Outcomes Research Program (OPORP)

• Clinical Research Award (CRA)
• Clinical Trial Award (CTA)

Pre-Application (Letter of Intent): May 4, 2022
Application: June 1, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/oporp

DoD FY22 Epilepsy Research Program (ERP)

• Idea Development Award (IDA)
• Research Partnership Award (RPA)
• Virtual Post- Traumatic Epilepsy Research Center Leadership Award
  (Virtual-P-TERC-L)
• Virtual Post- Traumatic Epilepsy Research Center Faculty Award
  (Virtual-P-TERC-F)

Pre-Application (Letter of Intent): May 19, 2022

Application: June 23, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/erp

DoD FY22 Breast Cancer Research Program (BCRP)

• Breakthrough Award Levels 1 and 2 (BTA12)      
• Era of Hope Scholar Award (EOHSA)      

Pre-Application (Letter of Intent): May 3, 2022

Application: May 17, 2022

Confidential Letters of Recommendation Submission Deadline: May 20, 2022

• Breakthrough Award Level 3 (BTA3)       
• Breakthrough Award Level 4 (BTA4)       
• Innovator Award (INNOV)          
• Transformative Breast Cancer Consortium Award (TBCCA)          

Pre-Application (Preproposal): April 28, 2022

Invited Application: July 27, 2022

 Link to Full Announcement: https://cdmrp.army.mil/funding/bcrp

DoD FY22 Amyotrophic Lateral Sclerosis Research Program (ALSRP)

• Pilot Clinical Trial Award              
• Clinical Biomarker Development Award
• Therapeutic Development Award           
• Therapeutic Idea Award              

Pre-Application (Preproposal): April 29, 2022

Invitation to Submit an Application: June 2022

Application: July 28, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/alsrp

DoD FY22 Lung Cancer Research Program (LCRP)

• Career Development Award (CDA)         
• Concept Award (CA)      

Pre-Application (Letter of Intent): May 3, 2022

Letter of Intent is required.

Application: May 17, 2022

• Clinical Translational Research Partnership Award (CTRPA)        

Pre-Application (Letter of Intent): July 13, 2022

Letter of Intent is required.

Application: July 27, 2022

• Idea Development Award (IDA)
• Investigator-Initiated Translational Research Award (IITRA)       

Pre-Application (Preproposal): May 4, 2022

Preproposal is required; application submission is by invitation only.

Application: July 27, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/lcrp

DOD FY22 Peer Reviewed Medical Research Program (PRMRP)

• Clinical Trial Award (CTA)            
• Focused Program Award (FPA) 

Pre-Application (Preproposal): May 6, 2022

Application: August 12, 2022

• Discovery Award (DA)  

Pre-Application (Letter of Intent): April 22, 2022

Application: May 20, 2022

• Investigator-Initiated Research Award (IIRA)     
• Technology/Therapeutic Development Award (TTDA)   

Pre-Application (Letter of Intent): April 29, 2022

Application: May 27, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/prmrp

HHS/CDC (Forecasted) Building Mathematical Modeling Workforce Capacity to Support Infectious Disease and Healthcare Research 

Description: The purpose of this notice of funding opportunity is to support pre-doctoral fellows’ innovative research to develop and apply computational tools and mathematical methods for modeling the spread of pathogens in healthcare settings (e.g., SARS-CoV-2, healthcare-associated infections [HAIs], antimicrobial resistant organisms [AROs]). This NOFO is intended to increase the number of junior modeling professionals that are trained and experienced in modeling transmission of pathogens in healthcare settings and to contribute to generalizable scientific knowledge through dissemination (e.g., pre-prints, peer-reviewed studies, scientific presentations). The application should be written by the PI/mentor who may or may not name specific pre-doctoral student(s) to conduct the research at the time of application submission.

Estimated Application Due Date: May 4, 2022

Link to Full Announcement: https://www.grants.gov/web/grants/view-opportunity.html?oppId=337897

Robert Wood Johnson Foundation Funding Opportunities

The Robert Wood Johnson Foundation funds a wide array of research and initiatives to help address some of America’s most pressing health challenges.

• Interdisciplinary Research Leaders

The Interdisciplinary Research Leaders program seeks teams of researchers and community members committed to working together improve health equity by dismantling structural racism.

Application Due Date: Wed, 4 May 2022

• Evidence for Action: Innovative Research to Advance Racial Equity

Evidence for Action prioritizes research to evaluate specific interventions that have the potential to contribute to dismantling and counteracting the harms of structural and systemic racism and improving health, well-being, and equity outcomes.

Application Due Date: Proposals will be accepted throughout the year on a rolling admission

• Pioneering Ideas: Exploring the Future to Build a Culture of Health

Pioneering Ideas: Exploring the Future to Build a Culture of Health welcomes proposals that are primed to influence health equity in the future.

Application Due Date: Proposals will be accepted throughout the year on a rolling admission

Link to Full Announcement: https://www.rwjf.org/en/how-we-work/grants-explorer/funding-opportunities.html

The International Center for Responsible Gaming (ICRG) 2022 Grants Program

Description: The ICRG awards grants on a competitive basis for a variety of research activities exploring the etiology, prevention and treatment of gambling disorder and the development and evaluation of responsible gambling strategies.

Large Grant: Up to $75,000/per year in direct costs for 2 years

Deadline for Letters of Intent: April 1, 2022

Application Deadline: June 30, 2022

Seed Grant: Up to $30,000/per year in direct costs for one year

Application Deadline: May 2, 2022

Link to Full Announcement: https://www.icrg.org/research-center/apply-icrg-funding

Southwest Center for Occupational and Environmental Health Pilot Projects Research Training Program

Description: The goal of the Pilot Projects Research Training Program is to enhance Southwest Center for Occupational and Environmental Health (SWCOEH) regional outreach efforts in research training and to foster stronger inter-institutional ties in occupational health research within Public Health Region 6 (PHR 6) (Arkansas, Louisiana, New Mexico, Oklahoma and Texas). The objective of this program is to provide a support mechanism for pilot research projects initiated by:

• Research Trainee Awards: Graduate doctoral students or postdoctoral fellows in an occupational health and safety-related discipline.
• Junior Investigator Awards: New investigators with research interests in the general area of occupational health and safety. Junior investigators are defined as faculty who have not served as PI on any Public Health Service (PHS)-supported research grants other than a R03, R15, R21, K01, K08, or K12.
• New Researcher Awards: Researcher or Faculty in areas other than occupational health research who wish to apply their expertise to an occupational safety and health issue.

Letters of Intent Due: March 15, 2022

Full proposals Due: April 15, 2022

Link to Full Announcement: https://sph.uth.edu/research/centers/swcoeh/pilot-projects/

The International Foundation for Ethical Research (IFER) – 2022-2023 GRADUATE FELLOWSHIPS FOR ALTERNATIVES TO THE USE OF ANIMALS IN SCIENCE

Description: IFER Graduate Fellowships are one-year grants for projects that support the development, acceptance and implementation of innovative scientific methodologies that advance science and refine, reduce or replace the use of animals in research, testing or education. Grants of $12,500 are typically awarded and are renewable annually for up to three years, depending on student progress and availability of funds. IFER recognizes the value in directing financial resources away from animal models and toward the development of human-relevant, non-animal models, as such resources pay higher dividends for human health when used for human-relevant research.

Pre-proposals Due: April 30, 2022

Link to Full Announcement: More information on the IFER Graduate Fellowship program, including eligibility requirements, submission guidelines, and a link to the online application can be found on the IFER website at www.ifer.org/fellowships.php.

Melanoma Research Alliance (MRA) Dermatology Fellowship & Junior Faculty Awards

Description: The aim of this training program is to drive greater interest and focus on melanoma in dermatologic clinical practice and research related to the prevention, detection, diagnosis, and staging of melanoma.

• MRA Dermatology Fellows Award – Supports dermatology residents, fellows, or post-docs in a dermatology program with research, and/or demonstration and pilot programs focused on melanoma prevention or improving early detection, diagnosis, or prognosis.
• MRA Dermatology Junior Faculty/Clinical Instructor Award - Supports new dermatology

faculty (clinical instructors or new assistant professors) working in research on melanoma

prevention or improving early detection, diagnosis, or prognosis.

Proposals Due: April 20, 2022

Link to Full Announcement: https://www.curemelanoma.org/research/request-for-proposals/dermatology-fellows-award